GM14182
LCL from B-Lymphocyte
Description:
WILLIAMS-BEUREN SYNDROME; WBS
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases dbGaP |
Class |
Disorders of Connective Tissue, Muscle, and Bone |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
ISCN
|
46,XY.ish del(7)(q11.23q11.23)(ELN-).arr 7q11.23(72363696-73780028)x1
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis and by Chromosome Analysis |
|
ELASTIN |
CCR FISH analysis with a probe for the elastin gene at 7q11.23 showed one of the chromosomes 7 to be deleted for the elastin gene for this Williams syndrome subject. |
|
Cytogenetics |
Chromosome 7: DELETION Aneuploid Segment (-)7q11>7q11 |
Remarks |
Failure to thrive; prolonged colic; hypervariable speech; good long-term memory; visuo-spatial problems; characteristic facial features; cardiovascular defects; hypercalcemia in childhood; abnormal gait; hoarse voice; strong attraction to music/perfect pitch |
Tang Z, Berlin DS, Toji L, Toruner GA, Beiswanger C, Kulkarni S, Martin CL, Emanuel BS, Christman M, Gerry NP, A dynamic database of microarray-characterized cell lines with various cytogenetic and genomic backgrounds G3 (Bethesda, Md)3:1143-9 2013 |
PubMed ID: 23665875 |
|
Merla G, Howald C, Henrichsen CN, Lyle R, Wyss C, Zabot MT, Antonarakis SE, Reymond A, Submicroscopic deletion in patients with williams-beuren syndrome influences expression levels of the nonhemizygous flanking genes American journal of human genetics79:332-41 2006 |
PubMed ID: 16826523 |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|